The Institute of Cancer Research has launched a new report which looks at how efficiently new cancer drugs licensed in Europe reach NHS patients here in the UK. The report looks at access to new cancer drugs to see where delays are occurring, consider why they might be happening and suggest possible solutions. Of particular interest is an interview with our very own Rob Lester, who speaks about his prostate cancer story and his successful treatment with abiraterone. Many of us will know Rob well as a member of the ELPCSG committee (now retired) and an enthusiastic member of the walking group. It’s great to hear his story. Please click here to read more abut the report and here to view the YouTube video featuring Rob.